NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $39,000 | -30.4% | 10,000 | 0.0% | 0.02% | -23.1% |
| Q1 2022 | $56,000 | -54.8% | 10,000 | 0.0% | 0.03% | -53.6% |
| Q4 2021 | $124,000 | -27.1% | 10,000 | 0.0% | 0.06% | -37.8% |
| Q3 2021 | $170,000 | +1.2% | 10,000 | 0.0% | 0.09% | +15.4% |
| Q2 2021 | $168,000 | -10.2% | 10,000 | 0.0% | 0.08% | -17.0% |
| Q1 2021 | $187,000 | 0.0% | 10,000 | 0.0% | 0.09% | -16.8% |
| Q4 2020 | $187,000 | -1.6% | 10,000 | -9.1% | 0.11% | -8.1% |
| Q3 2020 | $190,000 | -28.6% | 11,000 | 0.0% | 0.12% | +0.8% |
| Q2 2020 | $266,000 | +41.5% | 11,000 | +10.0% | 0.12% | +25.8% |
| Q1 2020 | $188,000 | -13.8% | 10,000 | 0.0% | 0.10% | 0.0% |
| Q4 2019 | $218,000 | +19.8% | 10,000 | 0.0% | 0.10% | -39.8% |
| Q3 2019 | $182,000 | – | 10,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 508,000 | $6,132,000 | 1.80% |
| Bodri Capital Management, LLC | 250,000 | $3,018,000 | 1.46% |
| Granahan Investment Management | 3,442,980 | $41,557,000 | 1.28% |
| TIRSCHWELL & LOEWY INC | 603,441 | $7,284,000 | 1.22% |
| NEA Management Company, LLC | 1,825,600 | $22,035,000 | 1.12% |
| Cormorant Asset Management, LP | 450,000 | $5,432,000 | 1.12% |
| HARVEY CAPITAL MANAGEMENT INC | 221,750 | $2,676,000 | 1.05% |
| Cheyne Capital Management (UK) LLP | 229,577 | $2,772,000 | 0.99% |
| Artal Group S.A. | 1,650,000 | $19,916,000 | 0.73% |
| FIC CAPITAL INC | 147,293 | $1,778,000 | 0.71% |